FI972719A0 - Menetelmä lamotrigiinin valmistamiseksi - Google Patents

Menetelmä lamotrigiinin valmistamiseksi

Info

Publication number
FI972719A0
FI972719A0 FI972719A FI972719A FI972719A0 FI 972719 A0 FI972719 A0 FI 972719A0 FI 972719 A FI972719 A FI 972719A FI 972719 A FI972719 A FI 972719A FI 972719 A0 FI972719 A0 FI 972719A0
Authority
FI
Finland
Prior art keywords
pct
sec
formula
date
lamotrigine
Prior art date
Application number
FI972719A
Other languages
English (en)
Swedish (sv)
Other versions
FI972719L (fi
FI972719A7 (fi
Inventor
Raymond Geoffrey Winter
David Alan Sawyer
Andrew Germain
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9426439A external-priority patent/GB9426439D0/en
Priority claimed from GB9426447A external-priority patent/GB9426447D0/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of FI972719A0 publication Critical patent/FI972719A0/fi
Publication of FI972719L publication Critical patent/FI972719L/fi
Publication of FI972719A7 publication Critical patent/FI972719A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075—Two hetero atoms, in positions 3 and 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI972719A 1994-12-30 1995-12-29 Menetelmä lamotrigiinin valmistamiseksi FI972719A7 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9426439A GB9426439D0 (en) 1994-12-30 1994-12-30 Process
GB9426447A GB9426447D0 (en) 1994-12-30 1994-12-30 Process
PCT/GB1995/003048 WO1996020934A1 (en) 1994-12-30 1995-12-29 Process for the preparation of lamotrigine

Publications (3)

Publication Number Publication Date
FI972719A0 true FI972719A0 (fi) 1997-06-24
FI972719L FI972719L (fi) 1997-08-27
FI972719A7 FI972719A7 (fi) 1997-08-27

Family

ID=26306284

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972719A FI972719A7 (fi) 1994-12-30 1995-12-29 Menetelmä lamotrigiinin valmistamiseksi

Country Status (13)

Country Link
US (1) US5912345A (fi)
EP (1) EP0800520B1 (fi)
JP (1) JPH11501007A (fi)
AT (1) ATE219487T1 (fi)
AU (1) AU4311596A (fi)
DE (1) DE69527153T2 (fi)
DK (1) DK0800520T3 (fi)
ES (1) ES2177672T3 (fi)
FI (1) FI972719A7 (fi)
HU (1) HU224688B1 (fi)
PT (1) PT800520E (fi)
RU (1) RU2145602C1 (fi)
WO (1) WO1996020934A1 (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6420354B1 (en) 1998-06-08 2002-07-16 Advanced Medicine, Inc. Sodium channel drugs and uses
GB9812413D0 (en) 1998-06-10 1998-08-05 Glaxo Group Ltd Compound and its use
US6479498B1 (en) 1999-06-04 2002-11-12 Theravance, Inc. Sodium channel drugs and uses
WO2001049669A1 (en) * 2000-01-03 2001-07-12 Rpg Life Sciences Limited A process for the preparation of 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine, commonly known as lamotrigine
DE10134980C2 (de) * 2001-07-17 2003-05-28 Helm Ag Verfahren zur Herstellung von Lamotrigin
CA2366521C (en) 2001-12-24 2007-03-06 Brantford Chemicals Inc. A new and efficient process for the preparation of lamotrigine and related 3,5-diamino-6-substituted-1,2,4-triazines
HU225667B1 (en) * 2002-09-20 2007-05-29 Richter Gedeon Nyrt Method for producing high-purity 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine
US20120142919A1 (en) * 2006-08-02 2012-06-07 Medichem, S.A. Method for synthesizing lamotrigine
US8486927B2 (en) * 2007-11-09 2013-07-16 Thar Pharmaceuticals Crystalline forms of lamotrigine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3637688A (en) * 1970-01-09 1972-01-25 American Home Prod 6-(fluoro and trifluoromethyl phenyl)-3 5-diamino - 1 2 4 - triazines and substituted - 6 - phenylalkyl-3,5-diamino-1 2 4-triazines
DK153787C (da) * 1979-06-01 1989-01-16 Wellcome Found Analogifremgangsmaade til fremstilling af substituerede 3,5-diamino-6-phenyl-1,2,4-triaziner og alfa-cyanobenzyliden-aminoguanidinforbindelser til anvendelse som mellemprodukter herved
EP0150677B1 (de) * 1984-01-11 1989-01-18 Ciba-Geigy Ag Herbizide und insektizide Triazinone
ATE39478T1 (de) * 1984-05-29 1989-01-15 Ciba Geigy Ag Verfahren zur herstellung von alphachloracetessigs|uremonomethylamid.
GB8613183D0 (en) * 1986-05-30 1986-07-02 Wellcome Found Triazine salt
GB9012312D0 (en) * 1990-06-01 1990-07-18 Wellcome Found Pharmacologically active cns compounds
GB9203483D0 (en) * 1992-02-19 1992-04-08 Wellcome Found Anti-inflammatory compounds

Also Published As

Publication number Publication date
RU2145602C1 (ru) 2000-02-20
EP0800520A1 (en) 1997-10-15
HUT77346A (hu) 1998-03-30
FI972719L (fi) 1997-08-27
DE69527153T2 (de) 2002-12-19
AU4311596A (en) 1996-07-24
JPH11501007A (ja) 1999-01-26
EP0800520B1 (en) 2002-06-19
DK0800520T3 (da) 2002-10-14
ATE219487T1 (de) 2002-07-15
HU224688B1 (hu) 2005-12-28
FI972719A7 (fi) 1997-08-27
ES2177672T3 (es) 2002-12-16
PT800520E (pt) 2002-11-29
WO1996020934A1 (en) 1996-07-11
US5912345A (en) 1999-06-15
DE69527153D1 (de) 2002-07-25

Similar Documents

Publication Publication Date Title
DK0828741T3 (da) Spirocykliske og bicykliske diazinyl- og carbazinyloxazolidinoner
BR9406362A (pt) Composto,processo para a preparação do mesmo e composição anti-nuclear
HUT70499A (en) Fluoroalkoxybenzaldehyde derivatives and process for producing them
HRP990167B1 (en) Sulphinic acid derivatives, method for producing them, and their use
FI972719A0 (fi) Menetelmä lamotrigiinin valmistamiseksi
PT97745A (pt) Processo de preparacao estero-selectiva de derivados da fenil-iso-serina
PL320167A1 (en) 2,2-dichloroalkanocarboxylic acids, method of obtaining them and therapeutic agents containing such compounds and their application in treating insulin immunity
ATE212018T1 (de) Thiazole oder imidazole derivate als maillard reaktion inhibitoren
ATE186836T1 (de) Verwendung von 1,5-dideoxy-1,5-imino-d-glucitol n-alkylderivaten zur behandlung von hepatitis b infektionen
BR9606817A (pt) Processo para preparar 4,6-dicloropirimidina
ATE168105T1 (de) Melamine derivate zur verwendung in der behandlung von krebs
DE59506121D1 (de) Verfahren zur herstellung von wasch- und reinigungsmitteltabletten durch mikrowellen- und heissluftbehandlung
BR9507168A (pt) Composto e processo para a preparação do mesmo
DE69606411D1 (de) Verfahren zur herstellung von liponsaeure
GB9325757D0 (en) Fluorination process
BR9407271A (pt) Beta-aminovinilcetonas processo de preparação e utilização das mesmas
DK0766660T3 (da) Cyclohexanonderivater, fremgangsmåde til deres fremstilling og mellemprodukter ved fremgangsmåden
ATE176463T1 (de) Verfahren zur herstellung von 2-substituierten 4,6-dialkoxypyrimidinen
ES2193524T3 (es) Procedimiento de preparacion de acido azetidino-2-carboxilico.
MX9302833A (es) Piridinas substituidas, proceso para su preparacion y composicion farmaceutica que las comprende.
DE69623767D1 (de) Verwendung von pyrrolidinderivaten zur behandlung des alkoholismus
PT970105E (pt) Processo para a preparacao de carboxamido-4-azasteroides
HUT51258A (en) Process for producing five-member nitrogenous heteroaromatic compounds
ATE258605T1 (de) Verfahren zur herstellung von (1r,4s)-2- azabicyclo 2.2.1 hept-5-en-3-on-derivaten
DK0809627T3 (da) Hidtil ukendte borneolderivater, fremgangsmåde til deres fremstilling og deres farmaceutiske anvendelse

Legal Events

Date Code Title Description
FD Application lapsed